4DMedical Limited (FDMDF)
USD 0.34
(0.0%)
USD 0.34
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -30.86 Million | -22.65 Million | -25.26 Million | -14.52 Million | -7.65 Million | -5.77 Million |
| Net Income | -35.97 Million | -31.45 Million | -24.59 Million | -21.42 Million | -21.97 Million | -6.49 Million |
| Depreciation & Amortization | 4.06 Million | 2.56 Million | 1.49 Million | 741.48 Thousand | 584.65 Thousand | 103.94 Thousand |
| Deferred income taxes | - | -1.01 Million | -613.95 Thousand | -1.5 Million | -2.49 Million | -828.31 Thousand |
| Stock-based compensation | - | 1.01 Million | 613.95 Thousand | 1.5 Million | 3.47 Million | 822.07 Thousand |
| Change in working capital | - | 4.8 Million | -2.75 Million | 4.61 Million | 2.98 Million | 240.11 Thousand |
| Other non-cash items | 9.17 Million | 1.43 Million | 582.09 Thousand | 1.54 Million | 9.77 Million | 374.26 Thousand |
| Investing Cash Flow | -40.04 Million | -1.61 Million | -3.5 Million | -580.44 Thousand | -786.44 Thousand | -1.03 Million |
| Investments in PPE | -302.87 Thousand | -1.61 Million | -3.07 Million | -353.32 Thousand | -1.15 Million | -1.28 Million |
| Acquisitions | -38.86 Million | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -39.73 Million | -882.41 Thousand | -422.62 Thousand | -227.12 Thousand | 372 Thousand | 253.4 Thousand |
| Financing Cash Flow | 31.93 Million | 42.72 Million | -995.47 Thousand | 87.55 Million | 13.78 Million | 8.23 Million |
| Debt repayment | - | -170.58 Thousand | -995.47 Thousand | -533.66 Thousand | -14.41 Million | -2 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -2.53 Million | - | -6.38 Million | - | - |
| Common Stock Issuance | 32.94 Million | 42.55 Million | - | 96 Million | -276.92 Thousand | 6.23 Million |
| Other Financing Activities | -3.06 Million | 2.7 Million | -995.47 Thousand | -2.06 Million | 17.13 Million | 6.23 Million |
| Accounts receivables | - | -1.82 Million | -2.01 Million | 868 Thousand | 467.29 Thousand | 396.75 Thousand |
| Accounts payables | - | 5.31 Million | 312.87 Thousand | 4.11 Million | 1.06 Million | 410.85 Thousand |
| Inventory | - | -663.5 Thousand | -273.13 Thousand | -137.32 Thousand | 612.71 Thousand | -605.95 Thousand |
| Other working capital | - | 1.97 Million | -779.18 Thousand | -228.19 Thousand | 833.78 Thousand | 38.46 Thousand |
| Cash at beginning of period | 69.57 Million | 51.11 Million | 80.88 Million | 8.42 Million | 3.08 Million | 1.66 Million |
| Cash at end of period | 30.6 Million | 69.57 Million | 51.11 Million | 80.88 Million | 8.42 Million | 3.08 Million |
| Capital Expenditure | -302.87 Thousand | -1.61 Million | -3.07 Million | -353.32 Thousand | -1.15 Million | -1.28 Million |
| Effect of forex changes on cash | - | - | - | - | - | -1.00 |
| Net cash flow / Change in cash | -38.97 Million | 18.46 Million | -29.76 Million | 72.45 Million | 5.34 Million | 1.42 Million |
| Free Cash Flow | -31.16 Million | -24.26 Million | -28.34 Million | -14.87 Million | -8.8 Million | -7.06 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -35.97 Million | -20.37 Million | -15.6 Million | -7.8 Million | -31.45 Million | -15.22 Million |
| Depreciation & Amortization | 4.06 Million | 2.54 Million | 1.51 Million | 499.81 Thousand | 2.56 Million | 1.35 Million |
| Deferred income taxes | - | - | - | - | -1.01 Million | -1.63 Million |
| Stock-based compensation | - | - | 497.38 Thousand | 497.38 Thousand | 1.01 Million | 358.46 Thousand |
| Change in working capital | - | - | - | - | 4.8 Million | -1.43 Million |
| Other non-cash items | 9.17 Million | 6.79 Million | 2.38 Million | -564.31 Thousand | 1.43 Million | -1.04 Million |
| Investing Cash Flow | -40.04 Million | -678.95 Thousand | -39.36 Million | -19.68 Million | -1.61 Million | -559.77 Thousand |
| Investments in PPE | -302.87 Thousand | 331.16 Thousand | -634.04 Thousand | -48.75 Thousand | -1.61 Million | -559.77 Thousand |
| Acquisitions | - | - | -38.72 Million | -19.36 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -39.73 Million | -39.73 Million | -268.26 Thousand | -268.26 Thousand | -882.41 Thousand | -135.51 Thousand |
| Financing Cash Flow | 31.93 Million | -467.96 Thousand | 32.4 Million | 16.2 Million | 42.72 Million | 42.02 Million |
| Debt repayment | - | - | - | - | -170.58 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -2.53 Million | - |
| Common Stock Issuance | 32.94 Million | - | 32.94 Million | - | 42.55 Million | 42.55 Million |
| Other Financing Activities | - | - | 16.2 Million | 16.2 Million | 2.7 Million | 21.01 Million |
| Accounts receivables | - | - | - | - | -1.82 Million | -266.15 Thousand |
| Accounts payables | - | - | - | - | 5.31 Million | - |
| Inventory | - | - | - | - | -663.5 Thousand | -331.75 Thousand |
| Other working capital | - | - | - | - | 1.97 Million | -838.93 Thousand |
| Cash at beginning of period | 69.57 Million | 47.87 Million | 69.57 Million | - | 51.11 Million | 45.74 Million |
| Cash at end of period | 30.6 Million | 30.6 Million | 47.87 Million | -10.84 Million | 69.57 Million | 69.57 Million |
| Capital Expenditure | -302.87 Thousand | 331.16 Thousand | -634.04 Thousand | -48.75 Thousand | -1.61 Million | -559.77 Thousand |
| Effect of forex changes on cash | - | - | -74.37 Thousand | - | - | - |
| Net cash flow / Change in cash | -38.97 Million | -17.27 Million | -21.69 Million | -10.84 Million | 18.46 Million | 23.83 Million |
| Free Cash Flow | -31.16 Million | -15.79 Million | -15.37 Million | -7.41 Million | -24.26 Million | -18.19 Million |
6674
BMHS
BSE
ENELAM
5215
0083